XML 53 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
Employee Benefit and Stock Compensation Plans Employee Benefit and Stock Compensation Plans (Tables)
12 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Restricted Stock Activity
Information regarding nonvested shares of restricted stock awards outstanding for the years ended March 31 is as follows:
 
2018
 
2017
 
Shares
 
Weighted Average
Grant Price
 
Shares
 
Weighted Average
Grant Price
Outstanding, beginning of year
3,200

 
$
5.56

 
4,000

 
$
5.56

Granted
1,000

 
3.48

 

 

Vested
(800
)
 
5.56

 
(800
)
 
5.56

Forfeited

 

 

 

Outstanding, end of year
3,400

 
$
4.52

 
3,200

 
$
5.56

Stock Options, Activity
Information regarding stock options as of and for the years ended March 31 is as follows:
 
2018
 
2017
 
Options
 
Weighted
Average
Exercise
Price
 
Options
 
Weighted
Average
Exercise
Price
Outstanding, beginning of year
4,133

 
$
8.53

 
5,924

 
$
81.65

Granted
1,000

 
3.48

 

 

Exercised

 

 

 

Expired/Forfeited

 

 
1,791

 
249.00

Outstanding, end of year
5,133

 
$
7.54

 
4,133

 
$
8.53

Exercisable, at year end
1,733

 
 
 
933

 
 


Shares Authorized under Stock Option Plans, by Exercise Price Range
Information regarding stock options as of March 31, 2018 is as follows :
 
 
 
Options Outstanding
 
Options Exercisable
Range of
Exercise Prices
 
Shares
 
Weighted
Average
Remaining
Life
 
Weighted
Average
Exercise
Price
 
Shares
 
Weighted
Average
Exercise
Price
$
3.00

$
5.00

 
1,000

 
9.71
 
$
3.48

 

 
$
3.48

$
5.00

$
5.99

 
4,000

 
7.23
 
$
5.56

 
1,600

 
$
5.56

90.00

$
104.85

 
133

 
2.36
 
97.50

 
133

 
97.50

 Total
 
 
5,133

 
 
 
 
 
1,733

 
 
Stock Options, Valuation Assumptions
The fair value of the option grants was estimated on the date of the grant using the Black-Scholes option pricing model applying the following weighted average assumptions for the years ended March 31:
 
2018
 
2017
Risk-free interest rate
2.74
%
 
N/A
Volatility
10
%
 
N/A
Expected life of option grants (years)
7.5

 
N/A